Bristol-Myers Squibb Co Stock Forecast for 2023 - 2025 - 2030

Updated on 02/01/2023

Stock Rating
2
Price Target
$83.00
Consensus
Outperform
Upside
14.47%
Analysts
0
Stock Rating
2
Upside
14.47%
Analysts
0
Price Target
$83.00

Bristol-Myers Squibb Co Stock Forecast and Price Target

If the average 2023 price target of $83.00 recently set by prominent experts for Bristol-Myers Squibb Co is met, there would be a potential upside of approximately 14.47% from the last closing price in January, 2023. The high estimate is $95.00, and the low is $60.00. If you're looking for information on Bristol-Myers Squibb Co stock, consider checking out the forecasts for comparable firms such as NasdaqGS:REGN.

$83.00

14.47% Upside

Outperform
Outperform

Bristol-Myers Squibb Co Fair Value Forecast for 2023 - 2025 - 2030

2023 Fair Value Forecast
$123.45
2024 Fair Value Forecast
$127.65
2025 Fair Value Forecast
$133.35
2026 Fair Value Forecast
$127.95
2027 Fair Value Forecast
$123.75
2028 Fair Value Forecast
$118.95
2029 Fair Value Forecast
$108.90
2030 Fair Value Forecast
$102.75
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
JNJ Stock Forecast Johnson & Johnson Outperform 11
$163.42 $181.05 10.45%
LLY Stock Forecast Eli Lilly and Outperform 16
$344.15 $333.19 16.23%
PFE Stock Forecast Pfizer Inc Outperform 3
$44.16 $53.97 19.23%
VRTX Stock Forecast Vertex Pharmaceuticals Inc Outperform 16
$323.10 $323.74 0.90%
ZTS Stock Forecast Zoetis Buy 18
$165.49 $207.87 23.87%

Bristol-Myers Squibb Co Revenue Forecast for 2023 - 2025 - 2030

2023 Rev Forecast
$48.66B
2024 Rev Forecast
$50.13B
2025 Rev Forecast
$51.08B
2026 Rev Forecast
$49.48B
2027 Rev Forecast
$47.55B
2028 Rev Forecast
$43.96B
2029 Rev Forecast
$39.19B
2030 Rev Forecast
$36.90B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
ALNY Stock Forecast Alnylam Pharmaceuticals Outperform 7
$226.40 $244.18 10.87%
BAX Stock Forecast Baxter International Outperform 17
$45.69 $62.83 26.94%
VTRS Stock Forecast Viatris Outperform 8
$12.15 $13.70 11.11%

Bristol-Myers Squibb Co Dividend per Share Forecast for 2023 - 2025 - 2030

2023 DPS Forecast
$2.25
2024 DPS Forecast
$2.37
2025 DPS Forecast
$2.44
2026 DPS Forecast
$2.45
2027 DPS Forecast
$2.10
2028 DPS Forecast
$2.10
2029 DPS Forecast
$2.10
2030 DPS Forecast
$2.10
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
UTHR Stock Forecast United Therapeutics Outperform 12
$263.17 $279.92 12.09%
CTLT Stock Forecast Catalent Outperform 15
$53.55 $76.00 36.32%
IONS Stock Forecast Ionis Pharmaceuticals Outperform 9
$39.87 $52.42 25.41%

Bristol-Myers Squibb Co Free Cash Flow Forecast for 2023 - 2025 - 2030

2023 FCF Forecast
$19.68B
2024 FCF Forecast
$19.61B
2025 FCF Forecast
$19.19B
2026 FCF Forecast
$19.10B
2027 FCF Forecast
$17.17B
2028 FCF Forecast
$16.36B
2029 FCF Forecast
$15.84B
2030 FCF Forecast
$14.89B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
CYTK Stock Forecast Cytokinetics Outperform 10
$42.45 $62.07 41.34%
BCPC Stock Forecast Balchem Outperform 18
$130.63 $163.67 25.55%
NEOG Stock Forecast Neogen Hold 16
$21.42 $37.00 19.05%

Bristol-Myers Squibb Co Net Income Forecast for 2023 - 2025 - 2030

2023 NI Forecast
$17.26B
2024 NI Forecast
$17.43B
2025 NI Forecast
$17.87B
2026 NI Forecast
$17.08B
2027 NI Forecast
$16.55B
2028 NI Forecast
$15.67B
2029 NI Forecast
$14.22B
2030 NI Forecast
$13.29B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
CORT Stock Forecast Corcept Therapeutics Outperform 16
$22.86 $0.00 29.05%
INDV Stock Forecast Indivior PLC Buy 14
£182.10 £3.79 -97.40%
PCRX Stock Forecast Pacira BioSciences Outperform 16
$39.25 $79.67 98.73%

Bristol-Myers Squibb Co EBITDA Forecast for 2023 - 2025 - 2030

2023 EBITDA Forecast
$21.50B
2024 EBITDA Forecast
$21.76B
2025 EBITDA Forecast
$21.84B
2026 EBITDA Forecast
$22.73B
2027 EBITDA Forecast
$19.18B
2028 EBITDA Forecast
$18.16B
2029 EBITDA Forecast
$14.60B
2030 EBITDA Forecast
$13.89B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
AMPH Stock Forecast Amphastar Pharmaceuticals Outperform 14
$30.25 $41.00 45.45%
IRWD Stock Forecast Ironwood Pharmaceuticals Hold 14
$11.52 $12.60 8.51%
SUPN Stock Forecast Supernus Pharmaceuticals Outperform 16
$41.02 $35.50 -17.11%

Bristol-Myers Squibb Co EBIT Forecast for 2023 - 2025 - 2030

2023 EBIT Forecast
$20.34B
2024 EBIT Forecast
$20.77B
2025 EBIT Forecast
$21.43B
2026 EBIT Forecast
$20.31B
2027 EBIT Forecast
$19.04B
2028 EBIT Forecast
$18.30B
2029 EBIT Forecast
$16.43B
2030 EBIT Forecast
$15.21B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
LGND Stock Forecast Ligand Pharmaceuticals Outperform 14
$69.70 $195.43 127.40%
MDGL Stock Forecast Madrigal Pharmaceuticals Outperform 4
$288.07 $170.08 -39.25%
USNA Stock Forecast USANA Health Sciences Hold 14
$58.44 $104.00 -2.46%

Bristol-Myers Squibb Co EPS Price Prediction Forecast for 2023 - 2025 - 2030

2023 EPS Forecast
$8.23
2024 EPS Forecast
$8.51
2025 EPS Forecast
$8.89
2026 EPS Forecast
$8.53
2027 EPS Forecast
$8.25
2028 EPS Forecast
$7.93
2029 EPS Forecast
$7.26
2030 EPS Forecast
$6.85
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
NasdaqCM:ARPO Stock Forecast Aerpio Pharmaceuticals - 6
$27.92 $0.00 10.35%
CPRX Stock Forecast Catalyst Pharmaceuticals Outperform 16
$15.49 $10.95 -22.53%
TGTX Stock Forecast TG Therapeutics Outperform 9
$15.23 $73.38 24.75%